Supraclavicular Versus Interscalene Block for Shoulder Surgery

Not Applicable

Completed

• Conditions: Pain
• Interventions: Procedure: Supraclavicular Block; Procedure: Interscalene Block; Drug: Bupivacaine; Device: Ultrasound

• Registration Number: NCT02486549
• Lead Sponsor: Tokat Gaziosmanpasa University

Brief Summary

The purpose of this study is to compare the supraclavicular block to interscalene block in patients undergoing arthroscopic shoulder surgery.

Detailed Description

The aim of this study is to evaluate the efficacy of the supraclavicular block in comparison with interscalene block on postoperative pain, quality of recovery and side effects in patients undergoing arthroscopic shoulder surgery under general anesthesia.

Study Timeline

• Study Start: 2015-06
• Study First Submitted: 2015-06-24
• Study First Submitted QC: 2015-06-26
• Study First Posted: 2015-07-01
• Status Verified: 2017-02
• Primary Completion: 2017-02
• Study Completion: 2017-02
• Last Update Submitted: 2017-02-20
• Last Update Posted: 2017-02-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

• Patients undergoing shoulder surgery in American Society of Anesthesiologists physical status I-II

Exclusion Criteria

• with a known allergy to study medications,
• chronic opioid use,
• ipsilateral upper limb neurological deficits,
• severe respiratory disease,
• coagulopathy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Supraclavicular Block	Supraclavicular Block	Ultrasound guided supraclavicular block with 20 ml of 0.25% bupivacaine will be performed
Supraclavicular Block	Ultrasound	Ultrasound guided supraclavicular block with 20 ml of 0.25% bupivacaine will be performed
Interscalene block	Ultrasound	Ultrasound guided inter scalene block with 20ml of 0.25% bupivacaine will be performed.
Interscalene block	Interscalene Block	Ultrasound guided inter scalene block with 20ml of 0.25% bupivacaine will be performed.
Supraclavicular Block	Bupivacaine	Ultrasound guided supraclavicular block with 20 ml of 0.25% bupivacaine will be performed
Interscalene block	Bupivacaine	Ultrasound guided inter scalene block with 20ml of 0.25% bupivacaine will be performed.

Primary Outcome Measures

Name	Time	Method
Postoperative Pain	up to postoperative 24 hours	The visual analog scale will be used for assessment

Secondary Outcome Measures

Name	Time	Method
Quality of recovery	in the postoperative 24 hours	The Quality of Recovery-40 (QR40) questionnaire will be used for assessment
Motor block	up to postoperative 24 hours	The muscle force will be evaluated with scale 0 to 3( 0:normal muscle force, 1: reduced muscle force, 2: impaired mobility 3: paralysis
Sensory block	up to postoperative 24 hours	The sensorial block will be assessed by pinprick test.
Adverse events	up to postoperative 24 hours	The number of patients with adverse events will be recorded.
Analgesics requirement time	up to postoperative 24 hours	the first intravenous analgesic requirement time will be recorded.
Systolic Blood pressure changes	at time of surgery	The blood pressure will be measured non invasively and the systolic blood pressure lower than 90 mmHg or decrease more than 20% of baseline will be accepted as a hypotension.
Heart rate changes	at time of surgery	The heart rate will be assessed via electrocardiographic monitoring and recorded as beat/minute.

Trial Locations

Locations (1)

Gaziosmanpasa University Medical School; 🇹🇷 Tokat, Turkey